Travere Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Travere Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2024.
  • Travere Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 866 %, a 125% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 866 +481 +125% Sep 30, 2024
Q2 2024 398 -158 -28.4% Jun 30, 2024
Q1 2024 350 -160 -31.4% Mar 31, 2024
Q4 2023 303 -189 -38.4% Dec 31, 2023
Q3 2023 386 +80.3 +26.3% Sep 30, 2023
Q2 2023 555 +331 +148% Jun 30, 2023
Q1 2023 510 +338 +197% Mar 31, 2023
Q4 2022 491 +357 +265% Dec 31, 2022
Q3 2022 305 +167 +121% Sep 30, 2022
Q2 2022 224 +91.6 +69% Jun 30, 2022
Q1 2022 172 +42.2 +32.6% Mar 31, 2022
Q4 2021 135 -6.61 -4.68% Dec 31, 2021
Q3 2021 138 -0.46 -0.33% Sep 30, 2021
Q2 2021 133 -11.5 -7.97% Jun 30, 2021
Q1 2021 130 -21.8 -14.4% Mar 31, 2021
Q4 2020 141 -4.64 -3.18% Dec 31, 2020
Q3 2020 139 +4.78 +3.57% Sep 30, 2020
Q2 2020 144 +15.9 +12.4% Jun 30, 2020
Q1 2020 151 +38.1 +33.6% Mar 31, 2020
Q4 2019 146 +48.7 +50% Dec 31, 2019
Q3 2019 134 +48.3 +56.4% Sep 30, 2019
Q2 2019 128 +56.8 +79.5% Jun 30, 2019
Q1 2019 113 +41.7 +58.1% Mar 31, 2019
Q4 2018 97.4 +25 +34.6% Dec 31, 2018
Q3 2018 85.8 +15.1 +21.4% Sep 30, 2018
Q2 2018 71.5 +0.32 +0.45% Jun 30, 2018
Q1 2018 71.7 +0.93 +1.31% Mar 31, 2018
Q4 2017 72.3 +4.29 +6.31% Dec 31, 2017
Q3 2017 70.7 +2.61 +3.84% Sep 30, 2017
Q2 2017 71.2 +2.58 +3.76% Jun 30, 2017
Q1 2017 70.8 -13.6 -16.1% Mar 31, 2017
Q4 2016 68 -36.8 -35.1% Dec 31, 2016
Q3 2016 68.1 -91.6 -57.4% Sep 30, 2016
Q2 2016 68.6 -244 -78.1% Jun 30, 2016
Q1 2016 84.4 -514 -85.9% Mar 31, 2016
Q4 2015 105 +854 Dec 31, 2015
Q3 2015 160 +908 Sep 30, 2015
Q2 2015 313 Jun 30, 2015
Q1 2015 598 Mar 31, 2015
Q4 2014 -749 Dec 31, 2014
Q3 2014 -748 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.